Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
ibuprofen	O
/	O
Ambien	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Left	O
SDH	B-Intracranial_haemorrhage
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
an	O
___	O
year-old	O
male	O
with	O
history	O
of	O
dementia,	B-Dementia
HTN,	O
bilateral	O
DVTs,	O
on	O
Coumadin	O
since	O
___.	O
He	O
had	O
2	O
falls	B-Falls
during	O
the	O
past	O
few	O
days,	O
with	O
another	O
fall	B-Falls
on	O
the	O
day	O
of	O
admission.	O
No	O
LOC	O
in	O
both	O
times.	O
Can't	O
remember	O
the	O
exact	O
cause	O
of	O
the	O
fall	B-Falls
(perhaps	O
unsteadiness)	O
but	O
remember	O
all	O
other	O
things	O
relate	O
to	O
the	O
fall.	B-Falls
Head	B-Intracranial_haemorrhage
CT	B-Intracranial_haemorrhage
from	O
OSH	O
demonstrated	O
9mm	O
acute	O
on	O
chronic	O
left	O
sdh.	B-Intracranial_haemorrhage
No	O
associated	O
mass	O
effect	O
or	O
midline	O
shift.	O
Transfered	O
to	O
___	O
ED	O
for	O
further	O
evaluation.	O
Past	O
Medical	O
History:	O
DVT	O
Glaucoma	B-Visual_impairment
Depression	O
Dementia	B-Dementia
Inguinal	O
hernia	O
repair	O
(___)	O
Social	O
History:	O
___	O
Family	O
History:	O
Non-contributory	O
Physical	O
Exam:	O
PHYSICAL	O
EXAM	O
ON	O
ADMISSION:	O
Vitals:	O
T:98.9	O
HR:58	O
BP:122/65	O
RR:18	O
99%	O
ra	O
Gen:	O
WD/WN,	O
comfortable,	O
NAD.	O
HEENT:	O
Pupils:PERRLA	O
Neck:	O
Supple.	O
Lungs:	O
CTA	O
bilaterally.	O
Cardiac:	O
RRR.	O
S1/S2.	O
Abd:	O
Soft,	O
NT,	O
BS+	O
Extrem:	O
Warm	O
and	O
well-perfused.	O
Neuro:	O
Mental	O
status:	O
Awake	O
and	O
alert,	O
cooperative	O
with	O
exam,	O
normal	O
affect.	O
Orientation:	O
Oriented	B-Unspecified_cognitive_impairment
to	O
person	O
and	O
date.	O
Language:	O
Speech	O
fluent	O
with	O
good	O
comprehension	O
and	O
repetition.	O
Naming	O
intact.	O
No	O
dysarthria	O
or	O
paraphasic	O
errors.	O
Cranial	O
Nerves:	O
I:	O
Not	O
tested	O
II:	O
Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light,	O
to	O
mm	O
bilaterally.	O
Visual	B-Visual_impairment
fields	B-Visual_impairment
are	O
full	O
to	O
confrontation.	O
III,	O
IV,	O
VI:	O
Extraocular	O
movements	O
intact	O
bilaterally	O
without	O
nystagmus.	O
V,	O
VII:	O
Facial	O
strength	O
and	O
sensation	O
intact	O
and	O
symmetric.	O
VIII:	O
Hearing	B-Hearing_impairment
intact	B-Hearing_impairment
to	O
voice.	O
IX,	O
X:	O
Palatal	O
elevation	O
symmetrical.	O
XI:	O
Sternocleidomastoid	O
and	O
trapezius	O
normal	O
bilaterally.	O
XII:	O
Tongue	O
midline	O
without	O
fasciculations.	O
Motor:	O
Normal	O
bulk	O
and	O
tone	O
bilaterally.	O
No	O
abnormal	O
movements,	O
tremors.	O
Strength	O
full	O
power	O
___	O
throughout.	O
No	O
pronator	O
drift	O
Sensation:	O
Intact	O
to	O
light	O
touch,	O
propioception,	O
pinprick	O
and	O
vibration	O
bilaterally.	O
Handedness:	O
Right	O
*****	O
PHYSICAL	O
EXAM	O
ON	O
DISCHARGE:	O
VS:	O
97.3	O
112/69	O
65	O
18	O
98%RA	O
GENERAL:	O
Cachectic.	O
Oriented	B-Unspecified_cognitive_impairment
to	O
self,	O
year,	O
___.	O
HEENT:	O
R	O
infraorbital	O
superficial	O
abrasion.	O
No	O
purulent	O
drainage	O
of	O
the	O
R	O
eye	O
today.	O
Sclerae	O
are	O
anicteric,	O
clear	O
OP,	O
MMM	O
NECK:	O
supple,	O
JVP	O
6cm	O
RESP:	O
CTAB	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV:	O
RRR,	O
Nl	O
S1,	O
S2,	O
No	O
MRG	O
ABD:	O
Soft,	O
NT/ND	O
bowel	O
sounds	O
present,	O
no	O
rebound	O
tenderness	O
or	O
guarding,	O
no	O
organomegaly	O
GU:	O
Foley	O
in	O
place,	O
no	O
urine	O
in	O
bag	O
EXT:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
NEURO:	O
Face	O
symmetric,	O
___	O
strength	O
___	O
bilaterally,	O
___	O
strength	O
UE	O
b/l	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
01:00AM	O
BLOOD	O
WBC-8.5	O
RBC-3.73*	O
Hgb-10.8*	O
Hct-33.6*	O
MCV-90	O
MCH-29.0	O
MCHC-32.1	O
RDW-13.4	O
RDWSD-43.9	O
Plt	O
___	O
___	O
01:00AM	O
BLOOD	O
Neuts-77.3*	O
Lymphs-11.7*	O
Monos-8.8	O
Eos-1.4	O
Baso-0.4	O
Im	O
___	O
AbsNeut-6.57*	O
AbsLymp-0.99*	O
AbsMono-0.75	O
AbsEos-0.12	O
AbsBaso-0.03	O
___	O
01:00AM	O
BLOOD	O
___	O
PTT-31.1	O
___	O
___	O
01:00AM	O
BLOOD	O
Glucose-93	O
UreaN-20	O
Creat-0.6	O
Na-142	O
K-3.8	O
Cl-105	O
HCO3-26	O
AnGap-15	O
___	O
01:22AM	O
BLOOD	O
Lactate-1.1	O
___	O
02:15AM	O
URINE	O
Color-Yellow	O
Appear-Cloudy	O
Sp	O
___	O
___	O
02:15AM	O
URINE	O
Blood-SM	O
Nitrite-NEG	O
Protein-30	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-8.5*	O
Leuks-LG	O
___	O
02:15AM	O
URINE	O
RBC-17*	O
WBC->182*	O
Bacteri-FEW	O
Yeast-MOD	O
Epi-0	O
OTHER	O
LABS:	O
___	O
07:13AM	O
BLOOD	O
TSH-3.0	O
___	O
07:13AM	O
BLOOD	O
VitB12-525	O
Folate-11.5	O
___	O
12:28PM	O
URINE	O
Color-Yellow	O
Appear-Hazy	O
Sp	O
___	O
___	O
12:28PM	O
URINE	O
Blood-SM	O
Nitrite-NEG	O
Protein-100	O
Glucose-NEG	O
Ketone-NEG	O
Bilirub-NEG	O
Urobiln-NEG	O
pH-6.5	O
Leuks-LG	O
IMAGING:	O
___:	O
CT	B-Intracranial_haemorrhage
HEAD	B-Intracranial_haemorrhage
Interval	O
decrease	O
in	O
size	O
of	O
a	O
small	O
left	O
subdural	B-Intracranial_haemorrhage
hematoma	B-Intracranial_haemorrhage
causing	O
only	O
minimal	O
residual	O
rightward	O
shift	O
of	O
the	O
typically	O
midline	O
structures.	O
No	O
new	O
hemorrhage	O
identified.	O
___:	O
LENIS	O
1.	O
Occlusive	O
or	O
nearly-occlusive	O
deep	O
venous	O
thrombus	O
in	O
the	O
LEFT	O
CFV,	O
extending	O
to	O
the	O
proximal	O
superficial	O
and	O
deep	O
femoral	O
veins.	O
Given	O
its	O
similar	O
location	O
compared	O
to	O
___,	O
it	O
is	O
not	O
possible	O
to	O
determine	O
whether	O
this	O
represents	O
residual	O
thrombus	O
or	O
acute	O
clot.	O
2.	O
No	O
deep	O
venous	O
thrombus	O
in	O
the	O
right	O
lower	O
extremity	O
veins.	O
___:	O
CT	B-Intracranial_haemorrhage
HEAD:	B-Intracranial_haemorrhage
IMPRESSION:	O
1.	O
Evolution	O
of	O
left	O
subdural	B-Intracranial_haemorrhage
hematoma.	B-Intracranial_haemorrhage
2.	O
No	O
evidence	O
of	O
new	O
hemorrhage.	O
3.	O
Stable	O
minimal	O
rightward	O
midline	O
shift.	O
4.	O
Stable	O
left	O
occipital	O
subgaleal	O
hematoma.	O
5.	O
Please	O
note	O
MRI	O
of	O
the	O
brain	O
is	O
more	O
sensitive	O
for	O
the	O
detection	O
of	O
acute	O
infarct.	O
DISCHARGE	O
LABS:	O
___	O
05:55AM	O
BLOOD	O
WBC-8.5	O
RBC-3.94*	O
Hgb-11.4*	O
Hct-36.2*	O
MCV-92	O
MCH-28.9	O
MCHC-31.5*	O
RDW-13.3	O
RDWSD-44.7	O
Plt	O
___	O
___	O
05:55AM	O
BLOOD	O
Glucose-110*	O
UreaN-15	O
Creat-0.6	O
Na-137	O
K-3.9	O
Cl-103	O
HCO3-28	O
AnGap-10	O
___	O
05:55AM	O
BLOOD	O
Calcium-8.6	O
Phos-2.4*	O
Mg-2.0	O
Brief	O
Hospital	O
Course:	O
Mr	O
___	O
is	O
a	O
___	O
hx	O
DVT	O
in	O
___	O
on	O
Coumadin,	O
dementia,	B-Dementia
chronic	O
indwelling	O
Foley,	O
s/p	O
Fall	O
with	O
acute	O
on	O
chronic	O
SDH	B-Intracranial_haemorrhage
without	O
need	O
for	O
surgical	O
intervention,	O
transferred	O
to	O
Geriatrics	O
for	O
confusion,	B-Delirium
long-term	O
anticoagulation	O
management.	O
ACTIVE	O
ISSUES:	O
#	O
s/p	O
Fall	B-Falls
with	O
Acute	O
on	O
Chronic	O
Subdural	B-Intracranial_haemorrhage
Hematoma:	B-Intracranial_haemorrhage
Mr.	O
___	O
was	O
admitted	O
to	O
___	O
on	O
___	O
for	O
close	O
neurological	O
monitoring.	O
His	O
INR	O
was	O
reversed	O
in	O
the	O
ED.	O
Repeat	O
imaging	O
demonstrated	O
interval	O
improvement	O
of	O
the	O
SDH.	B-Intracranial_haemorrhage
He	O
remained	O
at	O
his	O
neurologic	O
baseline	O
per	O
outpatient	O
providers.	O
Keppra	O
was	O
started	O
for	O
seizure	B-Seizures
prophylaxis.	O
He	O
was	O
mobilized	O
with	O
___	O
who	O
recommended	O
rehabilitation	O
at	O
discharge.	O
#	O
DVT	O
previously	O
on	O
Coumadin:	O
Anticoagulation	O
had	O
been	O
started	O
in	O
___	O
and	O
continued	O
since.	O
___	O
ultrasound	O
was	O
performed	O
here	O
with	O
chronic	O
clot	O
in	O
the	O
LLE;	O
this	O
was	O
reviewed	O
by	O
Vascular	O
Surgery	O
who	O
believed	O
the	O
patient	O
did	O
not	O
require	O
ongoing	O
systemic	O
anticoagulation	O
or	O
IVC	O
filter	O
based	O
on	O
the	O
chronic	O
nature	O
of	O
the	O
clot.	O
Coumadin	O
was	O
discontinued	O
here	O
and	O
on	O
discharge.	O
#	O
History	O
of	O
Dementia	B-Dementia
/	O
UTI:	B-Urinary_tract_infection
Patient	O
with	O
waxing/waning	O
medical	O
status,	O
from	O
oriented	B-Delirium
x3	B-Delirium
to	O
intermittent	O
confusion.	B-Delirium
Outpatient	O
baseline	O
is	O
that	O
he	O
is	O
slow	O
to	O
respond	O
to	O
questions,	O
and	O
will	O
sometimes	O
voluntarily	O
not	O
respond	O
to	O
questioning.	O
Other	O
contributors	O
could	O
include	O
legal	O
blindness	B-Visual_impairment
(reportedly	O
90%	O
blind	B-Visual_impairment
in	O
both	O
eyes),	O
possible	O
UTI	B-Urinary_tract_infection
(patient	O
admitted	O
on	O
Cipro	O
started	O
prior	O
to	O
admission,	O
outpatient	O
culture	O
was	O
growing	O
10K	O
colonies	O
each	O
of	O
three	O
organisms,	O
thought	O
commensal	O
flora,	O
so	O
this	O
medication	O
was	O
stopped;	O
for	O
+yeast	O
urine	O
culture	O
here	O
x2,	O
Geriatrics	O
started	O
diflucan	O
to	O
complete	O
a	O
14	O
day	O
course),	O
and	O
outpatient	O
benzodiazepines	O
(though	O
these	O
were	O
continued	O
so	O
as	O
not	O
to	O
precipitate	O
withdrawal).	O
TSH,	O
B12	O
and	O
Folate	O
were	O
all	O
within	O
normal	O
limits.	O
#	O
Glaucoma	B-Visual_impairment
/	O
Conjunctivitis:	O
Continued	O
home	O
Alphagan.	O
Held	O
home	O
Combigan	O
(not	O
on	O
formulary).	O
Started	O
erythromycin	O
eye	O
drops	O
for	O
purulent	O
secretions	O
from	O
the	O
R	O
eye,	O
improved.	O
#	O
Hypertension:	O
Continued	O
home	O
Norvasc.	O
TRANSITIONAL	O
ISSUES:	O
-	O
Diflucan	O
to	O
finish	O
___	O
-	O
Erythromycin	O
eye	O
ointment	O
to	O
finish	O
___	O
-	O
Patient	O
recommended	O
for	O
aspiration	O
precautions	O
with	O
modified	O
diet.	O
-	O
Recommended	O
to	O
have	O
physical	O
therapy	O
as	O
outpatient	O
-	O
Continue	O
Keppra	O
prophylaxis	O
until	O
seen	O
by	O
Neurosurgery	O
-	O
Please	O
call	O
___	O
to	O
schedule	O
a	O
follow-up	O
appointment	O
with	O
Dr.	O
___	O
in	O
4	O
weeks	O
(please	O
mention	O
you	O
will	O
need	O
a	O
Head	O
CT	O
without	O
Contrast	O
beforehand)	O
-	O
Please	O
call	O
the	O
___	O
at	O
___	O
with	O
any	O
questions	O
or	O
concerns	O
until	O
your	O
follow-up	O
appointment	O
-	O
Patient	O
is	O
no	O
longer	O
on	O
Coumadin	O
-	O
Patient	O
is	O
no	O
longer	O
taking	O
Norvasc	O
-	O
Encourage	O
patient	O
to	O
take	O
fluids	O
between	O
meals	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
DAILY	O
2.	O
Vyvanse	O
(lisdexamfetamine)	O
70	O
mg	O
oral	O
QWeekly	O
3.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
4.	O
ClonazePAM	O
0.5	O
mg	O
PO	O
DAILY	O
AT	O
2PM	O
5.	O
ClonazePAM	O
1	O
mg	O
PO	O
QHS	O
6.	O
Combigan	O
(brimonidine-timolol)	O
0.2-0.5	O
%	O
ophthalmic	O
BID	O
7.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
8.	O
Warfarin	O
1	O
mg	O
PO	O
4X/WEEK	O
(___)	O
9.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
10.	O
Warfarin	O
2.5	O
mg	O
PO	O
3X/WEEK	O
(___)	O
11.	O
Ciprofloxacin	O
HCl	O
250	O
mg	O
PO	O
Q12H	O
Discharge	O
Medications:	O
1.	O
LeVETiracetam	O
500	O
mg	O
PO	O
BID	O
2.	O
Brimonidine	O
Tartrate	O
0.15%	O
Ophth.	O
1	O
DROP	O
BOTH	O
EYES	O
DAILY	O
3.	O
ClonazePAM	O
0.5	O
mg	O
PO	O
DAILY	O
AT	O
2PM	O
4.	O
ClonazePAM	O
1	O
mg	O
PO	O
QHS	O
5.	O
Finasteride	O
5	O
mg	O
PO	O
DAILY	O
6.	O
Mirtazapine	O
15	O
mg	O
PO	O
QHS	O
7.	O
Acetaminophen	O
1000	O
mg	O
PO	O
Q8H	O
8.	O
Docusate	O
Sodium	O
200	O
mg	O
PO	O
BID	O
Hold	O
for	O
loose	O
stools.	O
9.	O
Erythromycin	O
0.5%	O
Ophth	O
Oint	O
0.5	O
in	O
BOTH	O
EYES	O
QID	O
conjunctivitis	O
Duration:	O
7	O
Days	O
Last	O
day	O
=	O
___.	O
Fluconazole	O
100	O
mg	O
PO	O
Q24H	O
Duration:	O
14	O
Days	O
Last	O
day	O
=	O
___.	O
11.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
Hold	O
for	O
loose	O
stools.	O
12.	O
Senna	O
8.6	O
mg	O
PO	O
BID	O
Hold	O
for	O
loose	O
stools.	O
13.	O
Combigan	O
(brimonidine-timolol)	O
0.2-0.5	O
%	O
ophthalmic	O
BID	O
14.	O
Vyvanse	O
(lisdexamfetamine)	O
70	O
mg	O
oral	O
QWeekly	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
___	O
Diagnosis:	O
Left	O
___	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
-	O
sometimes.	O
Level	O
of	O
Consciousness:	O
Lethargic	O
but	O
arousable.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	O
chair	O
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
Dear	O
Mr	O
___,	O
It	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you.	O
You	O
were	O
admitted	O
after	O
a	O
fall	B-Falls
with	O
a	O
bleed	B-Intracranial_haemorrhage
in	O
your	O
head	B-Intracranial_haemorrhage
that	O
is	O
stable	O
by	O
imaging.	O
You	O
are	O
being	O
started	O
on	O
treatment	O
for	O
a	O
yeast	O
urinary	B-Urinary_tract_infection
tract	B-Urinary_tract_infection
infection.	B-Urinary_tract_infection
You	O
will	O
also	O
receive	O
an	O
antibiotic	O
ointment	O
for	O
an	O
eye	O
infection.	O
Please	O
follow-up	O
with	O
your	O
outpatient	O
providers	O
as	O
below.	O
There	O
are	O
further	O
directions	O
from	O
the	O
Neurosurgical	O
team	O
below	O
that	O
you	O
should	O
follow.	O
We	O
wish	O
you	O
all	O
the	O
best,	O
Your	O
___	O
Team	O
Activity	O
Recommendations:	O
-	O
We	O
recommend	O
that	O
you	O
avoid	O
heavy	O
lifting,	O
running,	O
climbing,	O
or	O
other	O
strenuous	O
exercise	O
until	O
your	O
follow-up	O
appointment.	O
-	O
You	O
make	O
take	O
leisurely	O
walks	O
and	O
slowly	O
increase	O
your	O
activity	O
at	O
your	O
own	O
pace	O
once	O
you	O
are	O
symptom	O
free	O
at	O
rest.	O
___	O
try	O
to	O
do	O
too	O
much	O
all	O
at	O
once.	O
-	O
No	O
driving	O
while	O
taking	O
any	O
narcotic	O
or	O
sedating	O
medication.	O
-	O
If	O
you	O
experienced	O
a	O
seizure	B-Seizures
while	O
admitted,	O
you	O
are	O
NOT	O
allowed	O
to	O
drive	O
by	O
law.	O
Medication	O
Recommendations:	O
-	O
Please	O
do	O
NOT	O
take	O
any	O
blood	O
thinning	O
medication	O
(Aspirin,	O
Ibuprofen,	O
Plavix,	O
Coumadin)	O
until	O
cleared	O
by	O
your	O
Neurosurgeon.	O
-	O
You	O
have	O
been	O
discharged	O
on	O
Keppra	O
(Levetiracetam).	O
This	O
medication	O
helps	O
to	O
prevent	O
seizures.	B-Seizures
Please	O
continue	O
this	O
medication	O
as	O
indicated	O
on	O
your	O
discharge	O
instruction.	O
It	O
is	O
important	O
that	O
you	O
take	O
this	O
medication	O
consistently	O
and	O
on	O
time.	O
-	O
You	O
may	O
use	O
Acetaminophen	O
(Tylenol)	O
for	O
minor	O
discomfort	O
if	O
you	O
are	O
not	O
otherwise	O
restricted	O
from	O
taking	O
this	O
medication.	O
What	O
You	O
___	O
Experience	O
Following	O
your	O
Head	B-Intracranial_haemorrhage
Bleed:	B-Intracranial_haemorrhage
-	O
You	O
may	O
have	O
difficulty	O
paying	O
attention,	O
concentrating,	O
and	O
remembering	O
new	O
information.	O
-	O
Emotional	O
and/or	O
behavioral	O
difficulties	O
are	O
common.	O
-	O
Feeling	O
more	O
tired,	O
restlessness,	O
irritability,	O
and	O
mood	O
swings	O
are	O
also	O
common.	O
-	O
Constipation	B-Constipation
is	O
common.	O
Be	O
sure	O
to	O
drink	O
plenty	O
of	O
fluids	O
and	O
eat	O
a	O
high-fiber	O
diet.	O
If	O
you	O
are	O
taking	O
narcotics	O
(prescription	O
pain	O
medications),	O
try	O
an	O
over-the-counter	O
stool	O
softener.	O
Information	O
regarding	O
Headaches:	O
-	O
Headache	O
is	O
one	O
of	O
the	O
most	O
common	O
symptom	O
after	O
a	O
brain	B-Intracranial_haemorrhage
bleed.	B-Intracranial_haemorrhage
-	O
Most	O
headaches	O
are	O
not	O
dangerous	O
but	O
you	O
should	O
call	O
your	O
doctor	O
if	O
the	O
headache	O
gets	O
worse,	O
develop	O
arm	O
or	O
leg	O
weakness,	O
increased	O
sleepiness,	O
and/or	O
have	O
nausea	O
or	O
vomiting	O
with	O
a	O
headache.	O
-	O
Mild	O
pain	O
medications	O
may	O
be	O
helpful	O
with	O
these	O
headaches	O
but	O
avoid	O
taking	O
pain	O
medications	O
on	O
a	O
daily	O
basis	O
unless	O
prescribed	O
by	O
your	O
doctor.	O
-	O
There	O
are	O
other	O
things	O
that	O
can	O
be	O
done	O
to	O
help	O
with	O
your	O
headaches:	O
avoid	O
caffeine,	O
get	O
enough	O
sleep,	O
daily	O
exercise,	O
relaxation/meditation,	O
massage,	O
acupuncture,	O
heat	O
or	O
ice	O
packs.	O
Followup	O
Instructions:	O
___	O

